Information | |
---|---|
has gloss | eng: Tezosentan is a non-selective ETA and ETB receptor antagonist. It acts as a vasodilator and was designed as a therapy for patients with acute heart failure. Recent studies have shown however, that tezosentan does not improve dyspnea or reduce the risk of fatal or nonfatal cardiovascular events. |
lexicalization | eng: Tezosentan |
instance of | e/Model (art) |
Lexvo © 2008-2024 Gerard de Melo. Contact Legal Information / Imprint